Delving into the Latest Updates on KQB-198 with Synapse

Overview

Basic Info

Drug Type

Small molecule drug

Synonyms

Target-

Action-

Mechanism-

Therapeutic Areas

NeoplasmsHemic and Lymphatic Diseases

Active Indication

Philadelphia chromosome-positive chronic myeloid leukemia in chronic phaseAdvanced Malignant Solid Neoplasm

Inactive Indication-

Originator Organization

Kumquat Biosciences, Inc.

Active Organization

Kumquat Biosciences, Inc.

Inactive Organization-

License Organization-

Drug Highest PhasePhase 1

First Approval Date-

Regulation-

Login to view timeline

The goal of this clinical trial is to learn if KQB198 works to treat advanced hematologic malignancies in adults. It will also learn about the safety of KQB198. The main questions it aims to answer are:
* What is the safe dose of KQB198 by itself or in combination with other anti-cancer drugs?
* Does KQB198 alone or in combination with other anti-cancer drugs decrease the size of the tumor?
* What happens to KQB198 in the body?
Participants will:
* Take KQB198 daily, alone or in combination with another anti-cancer drug
* Visit the clinic about 8 times in the first 8 weeks, and then once every 4 weeks after that

Start Date09 Dec 2024

Sponsor / Collaborator

Kumquat Biosciences, Inc.

CTIS2024-511453-22-00

/ RecruitingPhase 1

- KQB198-101

Start Date29 Nov 2024

Sponsor / Collaborator

Kumquat Biosciences, Inc.

100 Clinical Results associated with KQB-198

Login to view more data

100 Translational Medicine associated with KQB-198

Login to view more data

100 Patents (Medical) associated with KQB-198

Login to view more data

100 Deals associated with KQB-198

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase	Phase 1	Poland	Kumquat Biosciences, Inc.	09 Dec 2024
Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase	Phase 1	United States	Kumquat Biosciences, Inc.	09 Dec 2024
Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase	Phase 1	Italy	Kumquat Biosciences, Inc.	09 Dec 2024
Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase	Phase 1	France	Kumquat Biosciences, Inc.	09 Dec 2024
Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase	Phase 1	Spain	Kumquat Biosciences, Inc.	09 Dec 2024
Advanced Malignant Solid Neoplasm	Phase 1	Spain	Kumquat Biosciences, Inc.	03 Jun 2024
Advanced Malignant Solid Neoplasm	Phase 1	United States	Kumquat Biosciences, Inc.	03 Jun 2024
Advanced Malignant Solid Neoplasm	Phase 1	Taiwan Province	Kumquat Biosciences, Inc.	03 Jun 2024
Advanced Malignant Solid Neoplasm	Phase 1	Italy	Kumquat Biosciences, Inc.	03 Jun 2024
Advanced Malignant Solid Neoplasm	Phase 1	France	Kumquat Biosciences, Inc.	03 Jun 2024